Prevention and Treatment of Bleeding with Direct Oral Anticoagulants.

Drugs
R Monroe Crawley, Rachel L Anderson

Abstract

Anticoagulant-related bleeding carries considerable morbidity and mortality. Major or life-threatening bleeding is among the most severe of these complications. As the number of patients treated with direct oral anticoagulants (DOACs) continues to increase, so does the number of DOAC-related bleeding events. The incidence of CRNM bleeding related to DOAC therapy ranges from 15 to 18% per 100-year patients, while the incidence of major bleeding ranges from 2.71 to 3.6%. Many of these bleeding events can be prevented with tailored dosing regimens or proper peri-procedural management. When unable to be prevented, DOAC-related bleeding can lead to significant long-term disability or death. Management with newer reversal agents such as andexanet alfa and idarucizumab, as well as prothrombin complex concentrates, may improve outcomes for patients with DOAC-related bleeding. The purpose of this review is to explore strategies for preventing and treating bleeding in patients receiving DOACs for anticoagulant therapy.

References

Jan 23, 2008·Journal of Thrombosis and Haemostasis : JTH·I PabingerUNKNOWN Beriplex P/N Anticoagulation Reversal Study Group
Sep 1, 2009·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN RE-LY Steering Committee and Investigators
Dec 8, 2009·The New England Journal of Medicine·Sam SchulmanUNKNOWN RE-COVER Study Group
Aug 13, 2011·The New England Journal of Medicine·Manesh R PatelUNKNOWN ROCKET AF Investigators
Aug 30, 2011·The New England Journal of Medicine·Christopher B GrangerUNKNOWN ARISTOTLE Committees and Investigators
Aug 30, 2011·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Amisha M ParikhRobert J Goldberg
Nov 14, 2012·Circulation·Jeffrey I WeitzJohn W Eikelboom
Jul 3, 2013·The New England Journal of Medicine·Giancarlo AgnelliUNKNOWN AMPLIFY Investigators
Sep 3, 2013·The New England Journal of Medicine·Harry R BüllerPhil Wells
Oct 18, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jens LutzKlaus Thürmel
Nov 21, 2013·The New England Journal of Medicine·Robert P GiuglianoUNKNOWN ENGAGE AF-TIMI 48 Investigators
Jan 5, 2014·British Journal of Haematology·Sam SchulmanShari Ghanny
May 20, 2015·Thrombosis Research·D M Adcock, R Gosselin
Jul 7, 2015·The American Journal of Medicine·Geoffrey D BarnesZachary D Goldberger
Sep 2, 2015·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Hein HeidbuchelPaulus Kirchhof
Sep 24, 2015·Journal of Thrombosis and Haemostasis : JTH·N KhorsandUNKNOWN Subcommittee on Control of Anticoagulation
Nov 13, 2015·The New England Journal of Medicine·Deborah M SiegalMark A Crowther
Apr 6, 2016·American Journal of Surgery·David T MartinMartin Schreiber
May 28, 2016·The New England Journal of Medicine·Alexander T CohenUNKNOWN APEX Investigators
Aug 16, 2016·Clinical Journal of the American Society of Nephrology : CJASN·Junichi IshigamiKunihiro Matsushita
Sep 21, 2016·Heart·A John CammUNKNOWN GARFIELD-AF Investigators
Sep 24, 2016·Journal of the American College of Cardiology·Yee C LauGregory Y H Lip
Dec 14, 2016·The New England Journal of Medicine·C Michael GibsonKeith A Fox
Feb 9, 2017·Circulation·Amish N RavalUNKNOWN American Heart Association Clinical Pharmacology Subcommittee of the Acute Cardiac Care and General Cardiology Committee of
Jul 12, 2017·The New England Journal of Medicine·Charles V PollackJeffrey I Weitz
Aug 29, 2017·The New England Journal of Medicine·Christopher P CannonUNKNOWN RE-DUAL PCI Steering Committee and Investigators
Sep 2, 2017·Vascular Health and Risk Management·Erika L HellenbartShannon W Finks
May 15, 2018·American Heart Journal·Noel ChanJonathan H Seltzer
Feb 8, 2019·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN ANNEXA-4 Investigators

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.